Starpharma Holdings Limited
http://www.starpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Starpharma Holdings Limited
Keeping Track: Spectrum Submits Poziotinib; US FDA Approves Daré’s Xaciato, Expands Heron Zynrelef Label
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Deal Watch: BMS Looks To Molecular Templates’ Engineered Toxin Bodies In Cancer
Plus recent deals involving AbbVie/Caribou, Sanofi/i2O, Merck & Co./Starpharma, Protalix/SarcoMed, Targovax/Papyrus, Medivir/Ubiquigent, Eton/Azurity
Starpharma’s Antibiotic-Free BV Gel Launched In The UK
Australian sexual health specialist Starpharma launches its innovative, antibiotic-free Viva Gel BV bacterial vaginosis treatment in the UK.
Signs Of Life In The Bacterial Vaginosis, Vulvovaginal Candidiasis Pipeline
Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Nanotechnology, Chips, etc.
- Other Names / Subsidiaries
-
- Dendritic Nanotechnologies Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice